Celanese director granted 0.675 phantom stock units

Celanese Corp director Kathryn Hill reported an acquisition of 0.675 shares of phantom stock on March 10, 2026.

Rhea-AI Filing Summary

Celanese Corp director Kathryn Hill reported an acquisition of 0.675 shares of phantom stock on March 10, 2026. This entry reflects dividend equivalents credited on compensation deferred under Celanese’s 2008 Deferred Compensation Plan. Each phantom share represents the right to receive one share of Celanese common stock, bringing her total phantom holdings to 1,141.194 shares.

Insider Trade Summary

Grant/Award: 0.675 shares

Grant/Award 1 txn

Insider Hill Kathryn

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock	0.675	$50.67	$34.20

Holdings After Transaction: Phantom Stock — 1,141.194 contracts (Direct)

Footnotes (2)

1. F1. Each share of phantom stock represents the right to receive one share of Common Stock.
2. F2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Celanese Corp (CE) report for Kathryn Hill?

Celanese director Kathryn Hill reported receiving 0.675 phantom stock shares on March 10, 2026. These were dividend equivalents on deferred compensation, not an open-market share purchase or sale, and increased her total phantom stock balance to 1,141.194 shares.

What is phantom stock in the Celanese Corp (CE) Form 4 filing?

In this filing, each share of phantom stock represents the right to receive one share of Celanese common stock. The phantom stock is credited under the company’s deferred compensation plan and settles in actual shares as provided by that plan’s terms.

Why did Kathryn Hill receive 0.675 phantom stock shares at Celanese (CE)?

The 0.675 phantom stock shares represent dividend equivalents on compensation she deferred under Celanese’s 2008 Deferred Compensation Plan. When dividends are paid on common stock, equivalent amounts are credited as phantom stock to deferred balances.

Does the Celanese (CE) Form 4 show an open-market trade by Kathryn Hill?

No, the Form 4 shows a grant-type acquisition coded as “A,” reflecting phantom stock credited as dividend equivalents. It is a compensation-related bookkeeping entry under a deferred compensation plan, not an open-market buy or sell transaction.

How many phantom stock shares does Kathryn Hill hold after this Celanese (CE) transaction?

After the March 10, 2026 credit of 0.675 phantom stock shares, Kathryn Hill holds a total of 1,141.194 phantom stock shares. Each phantom share is tied to one future share of Celanese common stock under the deferred compensation plan.

What plan governs the phantom stock reported for Celanese (CE) director Kathryn Hill?

The phantom stock relates to Celanese’s 2008 Deferred Compensation Plan. Under this plan, deferred compensation earns dividend equivalents, credited as phantom stock units that are later payable in Celanese common stock according to the plan’s provisions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/11/2026 - 04:42 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hill Kathryn

(Last) (First) (Middle)

C/O CELANESE CORPORATION

222 W. LAS COLINAS BLVD., SUITE 900N

(Street)

IRVING TX 75039

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/10/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock	(1)	03/10/2026		A		0.675		(2)	(2)	Common Stock	0.675	$50.67	1,141.194	D

Explanation of Responses:

1. Each share of phantom stock represents the right to receive one share of Common Stock.

2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan.

Remarks:

	/s/ Christine Dryden, Attorney-in-Fact for Kathryn Hill	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.